ID NOW COVID-19

Device Abbott Laboratories
Total Payments
$2.6M
Transactions
54
Doctors
7
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $27.50 1 1
2023 $34.87 1 1
2022 $980,132 25 1
2021 $1.6M 27 4

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $2.6M 47 99.9%
Consulting Fee $3,230 4 0.1%
Food and Beverage $90.47 3 0.0%

Payments by Type

Research
$2.6M
47 transactions
General
$3,320
7 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
Clinical Evaluation of the Investigational ID NOW COVID-19 Assay Abbott Laboratories $1.3M 0
ID NOW COVID-19 Abbott Laboratories $1.3M 0
Diagnostic Performance of the IDNow COVID19 Screening Test v Simplexa COVID19 Direct Assay COVID IDNow Abbott Laboratories $36,255 0
Evaluation of the Clinical Performance of the Influenza A & B 2 Test Abbott Laboratories $500.00 0

Top Doctors Receiving Payments for ID NOW COVID-19

Doctor Specialty Location Total Records
Unknown Rochester, NY $2.6M 47
, MD Emergency Medicine San Diego, CA $1,400 1
, MD Emergency Medicine Annapolis, MD $700.00 1
, MD Emergency Medicine Birmingham, AL $630.00 1
, M.D Public Health & General Preventive Medicine La Jolla, CA $500.00 1
, MD Family Medicine Anchorage, AK $34.87 1
, MD Pediatrics San Francisco, CA $28.10 1
, FNP Nurse Practitioner Tukwila, WA $27.50 1

About ID NOW COVID-19

ID NOW COVID-19 is a device associated with $2.6M in payments to 7 healthcare providers, recorded across 54 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.

Payment data is available from 2021 to 2024. In 2024, $27.50 was paid across 1 transactions to 1 doctors.

The most common payment nature for ID NOW COVID-19 is "Unspecified" ($2.6M, 99.9% of total).

ID NOW COVID-19 is associated with 4 research studies, including "Clinical Evaluation of the Investigational ID NOW COVID-19 Assay" ($1.3M).